Skip to main content
. 2020 Mar 11;2020:7531876. doi: 10.1155/2020/7531876

Table 2.

The genotype frequency of four significant loci between ITP patients and controls.

SNP Closest genes Chr Position P value in pooling GWAS Risk allele Genotypes Genotype frequency χ 2 OR (95% CI) P
Cases n (%) Controls n (%)
rs117503120 GBE1/LINC02027 3 81352557 6.45 × 10−9 G GG 235 (94.0) 215 (86.0) 7.28 0.43 (0.27–0.67) 0.026
GA 15 (6.0) 35 (14.0)
AA 0 (0.0) 0 (0.0)

rs4483616 TENM4 11 78824323 8.84 × 10−9 / / / / / / /
/ / / / / / /
/ / / / / / /

rs5998634 TIMP3/SYN3 22 33169115 8.06 × 10−8 T CC 212 (84.8) 238 (95.2) 12.5 3.19 (1.98–5.16) 0.0019
CT 36 (14.4) 12 (4.8)
TT 2 (0.8) 0 (0.0)

rs16866133 RBM45/OSBPL6 2 179022610 9.39 × 10−8 T TT 247 (99.5) 235 (94.0) 7.73 0.20 (0.08–0.49) 0.03
TG 3 (0.5) 15 (6.0)
GG 0 (0.0) 0 (0.0)

SNP, single nucleotide polymorphism; Chr, chromosome; ITP, primary immune thrombocytopenic; CI, confidence interval; the positions are based on the GRCh37 assembly. The significance threshold is P value <1.0 × 10−7.